4CPS-119 Effectiveness of capecitabine treatment in metastasic colorectal cancer in elderly patients

BACKGROUND: Age is the major risk factor for metastasic colorectal cancer (mCRC), with 70% of patients older than 70 years. Furthermore, elderly patients are not represented enough in cancer clinical trials, so there is a lack of information about these patients. PURPOSE: To analyse the effectivenes...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Hosp Pharm
Prif Awduron: Soler, JI García, Molina, OM García, García, FJ Gómez, Lozano, E González, Jiménez, MDM Ruiz, Sánchez, S Vicente, Carrasco, A Laorden, Gómez, A Ruiz, Nieto, MA de la Rubia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2018
Pynciau:
Section 4: Clinical pharmacy services
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535258/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.210
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg